EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Clinical phenotype of anticoagulant discontinuation and the long-term prognosis in atrial fibrillation patients with high bleeding risk: A report from the GLORIA-AF registry

Hongyu Liu, Tommaso Bucci, Steven Ho Man Lam, Yang Chen, Manlin Zhao, Giulio Francesco Romiti, Yang Liu, Brian Olshansky, Tze Fan Chao, Menno V Huisman, Kui Hong, Gregory Y H Lip und 1 weitere

Heart Rhythm · 2026

DOI: 10.1016/j.hrthm.2025.07.034 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Heart Rhythm, 2026. Verfasst von Hongyu Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University, and Liverpool Heart and Chest Hospital,…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Registries, Anticoagulants, Hemorrhage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Horizon 2020 Framework Programme, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Discontinuation of oral anticoagulants (OACs) in patients with atrial fibrillation (AF) at high risk of bleeding is commonly seen. OBJECTIVE: This study aimed to explore risk factors leading to OAC discontinuation and the impact on clinical events in patients with AF at high bleeding risk. METHODS: From the prospective, multicenter Global Registry on Long-Term Antithrombotic Treatment in Patients With Atrial Fibrillation study, we analyzed, by OAC discontinuation, all-cause death, cardiovascular (CV) death, major adverse CV events (MACEs), thromboembolism (TE), major bleeding, stroke, and myocardial infarction during follow-up. The hazard ratio (HR) and confidence interval (CI) were determined using Cox regression. RESULTS: Of 3131 patients (age 74.9 ± 7.3 years, 39.5% male) with a HAS-BLED score of ≥3, 633 (20.2%) stopped OAC during follow-up. After multivariate adjustment, age of ≥80 years (HR 1.26, 95% CI 1.05-1.50), older with frailty (HR 1.33, 95% CI 1.12-1.94), chronic kidney disease (HR 1.36, 95% CI 1.14-1.63), chronic obstructive pulmonary disease (HR 1.56, 95% CI 1.20-2.03), peripheral arterial disease (HR 1.38, 95% CI 1.03-1.87), multimorbidity (HR 1.68, 95% CI 1.20-2.36), and polypharmacy (HR 1.59, 95% CI 1.24-2.05) were associated with OAC discontinuation. The patients who stopped OACs during follow-up had a higher risk of all-cause death (HR 1.74, 95% CI 1.35-2.25), CV death (HR 2.01, 95% CI 1.34-3.03), MACE (HR 2.37, 95% CI 1.79-3.14), TE (HR 1.96, 95% CI 1.28-2.99), major bleeding (HR 4.35, 95% CI 2.79-6.78), stroke (HR 2.42, 95% CI 1.57-3.73), and myocardial infarction (HR 2.02, 95% CI 1.12-3.66) after OAC discontinuation. The incidence of OAC discontinuation was higher in the patients with vitamin K antagonist than non-vitamin K oral anticoagulants (23.1% vs 19.3, P = .026). OAC discontinuation rate was consistent across regions, and the risk of clinical events was similar in the vitamin K antagonist and non-vitamin K oral anticoagulant groups. CONCLUSION: Being an older patient with frailty and having chronic kidney disease, chronic obstructive pulmonary disease, peripheral arterial disease, multimorbidity, and polypharmacy were risk factors for OAC discontinuation. OAC discontinuation was independently associated with a higher risk of mortality, major bleeding, TE, and MACE in patients with AF at high risk of bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationRegistriesAnticoagulantsHemorrhageStrokeThromboembolismWithholding TreatmentHumansMaleAgedFemaleProspective StudiesRisk FactorsPrognosisRisk AssessmentFollow-Up StudiesTime FactorsAged, 80 and overPhenotypeAdministration, Oral

Stichwörter der Autor:innen

Atrial fibrillationBleeding riskClinical outcomeClinical phenotypeOral anticoagulation

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University, and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Department of Medical Genetics, The Second…
  • Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University, and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Department of Clinical Internal, Anesthesi…
  • Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University, and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
  • Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University, and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Department of Cardiology, Beijing Anzhen H…
  • Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University, and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Department of Translational and Precision…
  • Liverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool John Moores University, and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Department of Cardiovascular Medicine, The…

Förderung

  • China Scholarship Council
  • Horizon 2020 Framework Programme
  • National Institute for Health and Care Research
  • University of Liverpool

Zitieren

APA

Liu, H., Bucci, T., Lam, S. H. M., Chen, Y., Zhao, M., Romiti, G. F., Liu, Y., Olshansky, B., Chao, T. F., Huisman, M. V., Hong, K., Lip, G. Y. H., & GLORIA-AF investigators (2026). Clinical phenotype of anticoagulant discontinuation and the long-term prognosis in atrial fibrillation patients with high bleeding risk: A report from the GLORIA-AF registry. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2025.07.034

Vancouver

Liu H, Bucci T, Lam SHM, Chen Y, Zhao M, Romiti GF, et al. Clinical phenotype of anticoagulant discontinuation and the long-term prognosis in atrial fibrillation patients with high bleeding risk: A report from the GLORIA-AF registry. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2025.07.034

BibTeX
@article{Liu2026,
  author = {Liu, Hongyu and Bucci, Tommaso and Lam, Steven Ho Man and Chen, Yang and Zhao, Manlin and Romiti, Giulio Francesco and Liu, Yang and Olshansky, Brian and Chao, Tze Fan and Huisman, Menno V and Hong, Kui and Lip, Gregory Y H and GLORIA-AF investigators, GLORIA-AF investigators},
  title = {Clinical phenotype of anticoagulant discontinuation and the long-term prognosis in atrial fibrillation patients with high bleeding risk: A report from the GLORIA-AF registry},
  journal = {Heart Rhythm},
  year = {2026},
  doi = {10.1016/j.hrthm.2025.07.034}
}
Kostenlos starten →